| DEXCOM INC. DL-,001 |
| USA |
| Gesundheit |
| US2521311074 / A0D9T1 |
| DC4 (Frankfurt) / DXCM (NASDAQ) |
| FRA:DC4, ETR:DC4, DC4:GR, NASDAQ:DXCM |
| https://www.dexcom.com/ |
|
DexCom, Inc. is a leading medical technology company specializing in continuous glucose monitoring (CGM) systems for diabetes management. Its primary products deliver real-time glucose readings through small, wearable sensors that provide accurate, p..
>Volltext.. |
| 25159.66 Mio. EUR |
| 24272.69 Mio. EUR |
| 4180.68 Mio. EUR |
| 1121.38 Mio. EUR |
| 807.34 Mio. EUR |
| 2.08 EUR |
| 1201.65 Mio. EUR |
| 970.31 Mio. EUR |
| 1546.75 Mio. EUR |
| 1.09 |
| 8.76% |
| 62.78% |
| - |
| - |
| - |
| 2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 3.557.404 Euro. |
| DEXCOM |
| 31.07.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|